Acute Muscular and Vascular Responses to a Single Session of Exercise With BFR in COPD (NCT07668921) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Acute Muscular and Vascular Responses to a Single Session of Exercise With BFR in COPD
France40 participantsStarted 2026-11
Plain-language summary
Exercise training is a cornerstone of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD). However, some patients derive limited benefits from conventional exercise programs. Previous studies suggest that the magnitude of exercise-induced muscle fatigue is associated with training effectiveness, with patients unable to develop significant muscle fatigue ("non-fatiguers") showing smaller improvements in functional capacity and quality of life.
Blood flow restriction (BFR) exercise consists in performing physical exercise while applying external pressure to the proximal part of the exercising limb, thereby reducing oxygen delivery to the muscles and limiting metabolite clearance. This approach has been shown to induce significant muscular adaptations despite the use of low exercise intensities. Because exercise intensity in COPD patients is often constrained by ventilatory limitations, BFR training may enhance muscle adaptations while reducing respiratory stress, potentially improving the effectiveness of PR.
The primary objective of this monocentric randomized crossover study is to compare lower-limb muscle fatigue induced by a single exercise session performed with BFR versus a standard exercise session in patients with COPD.
Who can participate
Age range
45 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Negative pregnancy test and use of an acceptable contraceptive method throughout the study duration for women of childbearing potential
* Established COPD defined as obstructive ventilatory defect (FEV1/FVC \< 0.70 or below the 5th percentile)
* Resting lung hyperinflation defined as functional residual capacity \> 2.5 z-scores according to the Global Lung Function Initiative (GLI)
* Clinical stability of COPD for at least 3 months, with no recent exacerbation requiring treatment modification
* Covered by a national health insurance system
* Able and willing to provide written informed consent
Non-inclusion Criteria:
* Presence of a medical device incompatible with magnetic stimulation
* Inability to perform an exercise test on a cycle ergometer
* Any usual contraindication to exercise testing, including:
* Recent myocardial infarction (3-5 days)
* Unstable coronary insufficiency
* Severe stenotic valvular disease
* Uncontrolled arrhythmia with hemodynamic instability
* Recent unexplained syncope
* Uncontrolled heart failure
* Uncontrolled arterial hypertension (systolic blood pressure ≥200 mmHg and/or diastolic blood pressure ≥110 mmHg at rest)
* Acute thromboembolic disease and/or pulmonary edema
* Conditions contraindicating the use of blood flow restriction (BFR), including:
* Coagulation disorder
* Peripheral neuropathy
* Uncontrolled hypertension (\>160/100 mmHg)
* Peripheral arterial disease
* History of venous throm…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Muscle fatigue
Timeframe: Assessed 15-minutes before, and 3, 30, 60-minutes after exercise